Epstein-Barr Virus Detection in the Central Nervous System of HIV-Infected Patients.
Epstein–Barr virus (EBV)
central nervous system (CNS)
cerebrospinal fluid (CSF)
human immunodeficiency virus (HIV)
polymerase chain reaction (PCR)
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
22 Sep 2022
22 Sep 2022
Historique:
received:
13
06
2022
revised:
19
07
2022
accepted:
13
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Simply detecting Epstein-Barr virus deoxyribonucleic acid (EBV-DNA) is insufficient to diagnose EBV-associated diseases. The current literature around EBV-DNA detection from cerebrospinal fluid (CSF) in human immunodeficiency virus (HIV)-positive non-lymphoma patients was systematically reviewed and a meta-analysis reporting the estimated pooled prevalence in this population when PCR methods are employed, targeting different sequence segments within the EBV genome, was conducted. Using a combination of three key concepts-Epstein-Barr virus detection, central nervous system disease, and human cerebrospinal fluid-and their MeSH terms, the PubMed database was searched. A total of 273 papers reporting the detection of EBV in CNS were screened, of which 13 met the inclusion criteria. The meta-analysis revealed a pooled prevalence of EBV-DNA in CSF of 20% (CI: 12-31%). The highest pooled prevalence was from studies conducted on the African population at 39% (CI: 27-51%). The investigation of the presence of EBV-DNA in the CSF was also very varied, with several gene targets used. While most patients from the articles included in this review and meta-analysis were symptomatic of CNS disorders, the pathogenicity of EBV in non-lymphoma HIV patients when detected in CSF has still not been determined. The presence of EBV-DNA in the CNS remains a concern, and further research is warranted to understand its significance in causing CNS disorders.
Identifiants
pubmed: 36297137
pii: pathogens11101080
doi: 10.3390/pathogens11101080
pmc: PMC9607430
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
AIDS Res Ther. 2017 May 2;14:24
pubmed: 28469695
Int J Infect Dis. 2014 Mar;20:52-7
pubmed: 24406738
J Clin Virol. 2008 Aug;42(4):433-6
pubmed: 18455472
Science. 2022 Jan 21;375(6578):296-301
pubmed: 35025605
Lancet Oncol. 2009 Apr;10(4):321-2
pubmed: 19350698
New Microbiol. 1998 Jan;21(1):77-9
pubmed: 9497932
Ther Adv Neurol Disord. 2012 Sep;5(5):279-96
pubmed: 22973424
N Engl J Med. 2004 Mar 25;350(13):1328-37
pubmed: 15044644
Front Immunol. 2020 Jan 31;11:70
pubmed: 32082325
Pathology. 2002 Oct;34(5):446-50
pubmed: 12408344
Biomed Pharmacother. 2022 Jan;145:112392
pubmed: 34781140
J Clin Pathol. 2019 Oct;72(10):651-658
pubmed: 31315893
Trans R Soc Trop Med Hyg. 2017 Oct 1;111(10):464-471
pubmed: 29373741
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
AIDS. 2002 May 3;16(7):993-1001
pubmed: 11953465
Am J Trop Med Hyg. 2015 Feb;92(2):274-9
pubmed: 25385864
J Clin Microbiol. 2000 Aug;38(8):3061-7
pubmed: 10921978
J Immunol. 2011 May 15;186(10):5854-62
pubmed: 21460204
J Gen Virol. 1994 Jan;75 ( Pt 1):95-100
pubmed: 8113744
J Clin Microbiol. 2005 Jul;43(7):3484-6
pubmed: 16000485
J Clin Invest. 2017 Jun 30;127(7):2513-2522
pubmed: 28628043
Clin Infect Dis. 2004 Jun 1;38(11):1629-32
pubmed: 15156453
J Infect Dis. 2009 Jan 1;199(1):31-8
pubmed: 19032105
Pathogens. 2020 Feb 06;9(2):
pubmed: 32041355
Viruses. 2020 Jul 16;12(7):
pubmed: 32708700
J Infect Dis. 2012 Jan 1;205(1):106-10
pubmed: 22075766
AIDS. 2012 Jun 19;26(10):1231-41
pubmed: 22706009
AIDS. 1996 Aug;10(9):951-8
pubmed: 8853727
J Neurol Neurosurg Psychiatry. 1998 Aug;65(2):191-5
pubmed: 9703169
J Neurovirol. 2002 Oct;8(5):432-8
pubmed: 12402169
Sci Rep. 2019 Jul 8;9(1):9829
pubmed: 31285478
PLoS Pathog. 2016 Apr 20;12(4):e1005549
pubmed: 27096949
J Virol. 2017 Oct 13;91(21):
pubmed: 28835490
Pan Afr Med J. 2018 Mar 28;29:181
pubmed: 30061959
Front Oncol. 2018 Jun 13;8:211
pubmed: 29951372
BMC Infect Dis. 2011 Oct 21;11:281
pubmed: 22018204
Rev Bras Hematol Hemoter. 2011;33(5):383-8
pubmed: 23049344
Blood. 2009 Jun 18;113(25):6372-81
pubmed: 19351961
Cancers (Basel). 2018 Jun 13;10(6):
pubmed: 29899236
J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46
pubmed: 34705104
Curr Infect Dis Rep. 2016 Nov;18(11):35
pubmed: 27686677
Virology. 1992 Sep;190(1):168-75
pubmed: 1356286
Diagn Microbiol Infect Dis. 2014 Nov;80(3):207-15
pubmed: 25178670
J Infect Dis. 2013 Jun 15;207(12):1798-806
pubmed: 23493724
J Neurovirol. 2007 Oct;13(5):446-51
pubmed: 17994429
PLoS One. 2015 Mar 25;10(3):e0120710
pubmed: 25807555
Front Oncol. 2020 Sep 30;10:1723
pubmed: 33102204
Blood. 2005 Nov 1;106(9):3166-74
pubmed: 16014568
Clin Infect Dis. 2014 Jun;58(12):1771-7
pubmed: 24668125
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
J Mol Diagn. 2004 Nov;6(4):378-85
pubmed: 15507678
Clin Microbiol Infect. 1998;4(10):577-584
pubmed: 11864246
Front Mol Biosci. 2022 Jan 10;8:816098
pubmed: 35083281
Rev Med Virol. 2015 Mar;25(2):71-84
pubmed: 25430668
J Infect Dis. 2014 Aug 1;210(3):392-9
pubmed: 24550442
J Med Virol. 2017 Mar;89(3):373-387
pubmed: 27430663
New Microbiol. 2009 Oct;32(4):333-40
pubmed: 20128439
Infection. 2013 Feb;41(1):27-31
pubmed: 22798048
HIV Med. 2007 Jul;8(5):306-11
pubmed: 17561877
Neurology. 1997 May;48(5):1351-5
pubmed: 9153472
Viruses. 2010 Apr;2(4):867-879
pubmed: 21994658
Front Immunol. 2018 Oct 04;9:2291
pubmed: 30337929